Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.

[1]  L. Feuk,et al.  Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability , 2017, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[2]  M. Tarnopolsky,et al.  Clinical Manifestations Associated With the N-Terminal-Acetyltransferase NAA10 Gene Mutation in a Girl: Ogden Syndrome. , 2017, Pediatric neurology.

[3]  Yufeng Shen,et al.  Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands , 2017, Nature Genetics.

[4]  Xiaodong Cheng,et al.  The Role of N-α-acetyltransferase 10 Protein in DNA Methylation and Genomic Imprinting. , 2017, Molecular cell.

[5]  K. Réblová,et al.  DNA mutation motifs in the genes associated with inherited diseases , 2017, PloS one.

[6]  Wyeth W Wasserman,et al.  Assessment of the ExAC data set for the presence of individuals with pathogenic genotypes implicated in severe Mendelian pediatric disorders , 2017, Genetics in Medicine.

[7]  P. Visscher,et al.  New mutations, old statistical challenges , 2017, bioRxiv.

[8]  Bradley P. Coe,et al.  Targeted sequencing identifies 91 neurodevelopmental disorder risk genes with autism and developmental disability biases , 2017, Nature Genetics.

[9]  W. Chung,et al.  Clinical application of whole-exome sequencing across clinical indications , 2015, Genetics in Medicine.

[10]  T. Arnesen,et al.  Expanding the Phenotype Associated with NAA10‐Related N‐Terminal Acetylation Deficiency , 2016, Human mutation.

[11]  G. Lyon,et al.  Proteomic and genomic characterization of a yeast model for Ogden syndrome , 2016, bioRxiv.

[12]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[13]  Stephan J Sanders,et al.  De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies , 2015, Science.

[14]  J. Casey,et al.  NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment , 2015, Scientific Reports.

[15]  D. Valle,et al.  GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same Gene , 2015, Human mutation.

[16]  T. Jensen,et al.  Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes , 2015, Nature Reviews Molecular Cell Biology.

[17]  G. Lyon,et al.  The biological functions of Naa10 - From amino-terminal acetylation to human disease. , 2015, Gene.

[18]  T. Arnesen,et al.  (Hyper)tension release by N-terminal acetylation. , 2015, Trends in biochemical sciences.

[19]  Céline Marionneau,et al.  Regulation of the cardiac Na+ channel NaV1.5 by post-translational modifications. , 2015, Journal of molecular and cellular cardiology.

[20]  A. Varshavsky,et al.  Control of mammalian G protein signaling by N-terminal acetylation and the N-end rule pathway , 2015, Science.

[21]  N. Reuter,et al.  Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects , 2014, Human molecular genetics.

[22]  Xiang Li,et al.  Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions , 2014, Genetics in Medicine.

[23]  T. Arnesen,et al.  De novo missense mutations in the NAA10 gene cause severe non-syndromic developmental delay in males and females , 2014, European Journal of Human Genetics.

[24]  Magalie S Leduc,et al.  Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.

[25]  Eric Vilain,et al.  Clinical exome sequencing for genetic identification of rare Mendelian disorders. , 2014, JAMA.

[26]  R. Brugada,et al.  Identification of N-terminal protein acetylation and arginine methylation of the voltage-gated sodium channel in end-stage heart failure human heart. , 2014, Journal of molecular and cellular cardiology.

[27]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.

[28]  Stephan J Sanders,et al.  A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.

[29]  S. Sindi,et al.  Amyloid-Associated Activity Contributes to the Severity and Toxicity of a Prion Phenotype , 2014, Nature Communications.

[30]  R. Gutenkunst,et al.  Loss of N-terminal Acetylation Suppresses A Prion Phenotype By Modulating Global Protein Folding , 2014, Nature Communications.

[31]  T. Serio,et al.  Defining the limits: Protein aggregation and toxicity in vivo , 2014, Critical reviews in biochemistry and molecular biology.

[32]  A. Varshavsky,et al.  The N-Terminal Methionine of Cellular Proteins as a Degradation Signal , 2014, Cell.

[33]  R. Chadwick,et al.  A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes Lenz microphthalmia syndrome , 2014, Journal of Medical Genetics.

[34]  T. Arnesen,et al.  A Saccharomyces cerevisiae Model Reveals In Vivo Functional Impairment of the Ogden Syndrome N-Terminal Acetyltransferase NAA10 Ser37Pro Mutant* , 2014, Molecular & Cellular Proteomics.

[35]  Caroline F. Wright,et al.  DECIPHER: database for the interpretation of phenotype-linked plausibly pathogenic sequence and copy-number variation , 2013, Nucleic Acids Res..

[36]  G. Lyon,et al.  The N-Terminal Methionine of Cellular Proteins as a Degradation Signal , 2014 .

[37]  Magalie S Leduc,et al.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.

[38]  D. Goldstein,et al.  Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes , 2013, PLoS genetics.

[39]  Ronen Marmorstein,et al.  Molecular Basis for Amino-Terminal Acetylation by the Heterodimeric NatA Complex , 2013, Nature Structural &Molecular Biology.

[40]  C. Shou,et al.  N‐α‐acetyltransferase 10 protein is a negative regulator of 28S proteasome through interaction with PA28β , 2013, FEBS letters.

[41]  A. Varshavsky,et al.  Control of protein quality and stoichiometries by N-terminal acetylation and the N-end rule pathway. , 2013, Molecular cell.

[42]  Murim Choi,et al.  De novo mutations in histone modifying genes in congenital heart disease , 2013, Nature.

[43]  T. Arnesen,et al.  N-Terminal Acetylation by NatC Is Not a General Determinant for Substrate Subcellular Localization in Saccharomyces cerevisiae , 2013, PloS one.

[44]  T. Arnesen,et al.  Protein N-terminal acetyltransferases in cancer , 2013, Oncogene.

[45]  E. Yu,et al.  Clinical Implications of Arrest-Defective Protein 1 Expression in Hepatocellular Carcinoma: A Novel Predictor of Microvascular Invasion , 2012, Digestive Diseases.

[46]  D. Horn,et al.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.

[47]  J. Bavarva,et al.  Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis , 2012, Proceedings of the National Academy of Sciences.

[48]  J. Harper,et al.  N-Terminal Acetylation Acts as an Avidity Enhancer Within an Interconnected Multiprotein Complex , 2011, Science.

[49]  H. Hakonarson,et al.  Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency. , 2011, American journal of human genetics.

[50]  Poshen B. Chen,et al.  N-α-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42/Rac1 activity. , 2011, Cancer cell.

[51]  H. Yang,et al.  Up-regulation of human arrest-defective 1 protein is correlated with metastatic phenotype and poor prognosis in breast cancer. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[52]  Daniel Auerbach,et al.  The N-end rule pathway is mediated by a complex of the RING-type Ubr1 and HECT-type Ufd4 ubiquitin ligases , 2010, Nature Cell Biology.

[53]  Xiaodong Cheng,et al.  hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. , 2010, The Journal of clinical investigation.

[54]  Alexander Varshavsky,et al.  N-Terminal Acetylation of Cellular Proteins Creates Specific Degradation Signals , 2010, Science.

[55]  H. Dinh,et al.  The Chaperone-Like Protein HYPK Acts Together with NatA in Cotranslational N-Terminal Acetylation and Prevention of Huntingtin Aggregation , 2010, Molecular and Cellular Biology.

[56]  R. Evjenth,et al.  Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans , 2009, Proceedings of the National Academy of Sciences.

[57]  N. Bhattacharyya,et al.  HYPK, a Huntingtin interacting protein, reduces aggregates and apoptosis induced by N-terminal Huntingtin with 40 glutamines in Neuro2a cells and exhibits chaperone-like activity. , 2008, Human molecular genetics.

[58]  J. Lillehaug,et al.  Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-α-acetyltransferase complex , 2006, Oncogene.

[59]  S. Munro,et al.  An N-terminally acetylated Arf-like GTPase is localised to lysosomes and affects their motility , 2006, Journal of Cell Science.

[60]  J. Lillehaug,et al.  Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex. , 2006, Oncogene.

[61]  M. Lanotte,et al.  Identification and characterization of the human ARD1-NATH protein acetyltransferase complex. , 2005, The Biochemical journal.

[62]  Y. Kirino,et al.  Interaction of N-Terminal Acetyltransferase with the Cytoplasmic Domain of β-Amyloid Precursor Protein and Its Effect on Aβ Secretion , 2005 .

[63]  Y. Kirino,et al.  Interaction of N-terminal acetyltransferase with the cytoplasmic domain of beta-amyloid precursor protein and its effect on A beta secretion. , 2005, Journal of biochemistry.

[64]  T. Stevens.  Faculty Opinions recommendation of Golgi targeting of ARF-like GTPase Arl3p requires its Nalpha-acetylation and the integral membrane protein Sys1p. , 2004 .

[65]  Rudy Behnia,et al.  Targeting of the Arf-like GTPase Arl3p to the Golgi requires N-terminal acetylation and the membrane protein Sys1p , 2004, Nature Cell Biology.

[66]  R. Corriveau,et al.  An Evolutionarily Conserved N-terminal Acetyltransferase Complex Associated with Neuronal Development* , 2003, Journal of Biological Chemistry.

[67]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[68]  L. Akslen,et al.  NATH, a novel gene overexpressed in papillary thyroid carcinomas , 2002, Oncogene.

[69]  R. Corriveau,et al.  N-Methyl-d-aspartate Receptors Regulate a Group of Transiently Expressed Genes in the Developing Brain* , 2001, The Journal of Biological Chemistry.

[70]  Susumu,et al.  Identification and characterization of genes and mutants for an N‐terminal acetyltransferase from yeast. , 1989, The EMBO journal.

[71]  Taylor,et al.  Model for the participation of quasi-palindromic DNA sequences in frameshift mutation. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[72]  Yi,et al.  The Role of N-alpha-acetyltransferase 10 Protein in DNA Methylation and Genomic Imprinting , 2022 .